038460 fundamentals
Key facts
BioSmart Co., Ltd. engages in the manufacture and sale of smart cards and related systems. It operates through the following business divisions: Smart Card, Medicines, Mainstream Payment, Book Publishing, Diagnosis Kit, and Heavy Copper Products. The Smart Card business division offers credit cards, IC cards, free-form cards, and various entry cards. The Medicines business division is involved in the prescription drugs and over-the-counter drugs such as daconazole and rivatan tablets. The Mainstream Payment business division focuses on mainstream payment agency, payment terminal, and dionysus. The Book Publishing business division refers to hardcover books, shigong magazines, and book clubs. The Diagnosis Kit business division consists of corona diagnostic kit. The Heavy Copper Products business division includes flat copper wire, enameled copper wire for winding coils of transformers, rotating machines, and generator. The company was founded on December 30, 1985 and is headquartered in Seoul, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
Financial health
Financial position and solvency of the company